ESE's White Paper launch
ESE White Paper launch event
04 May 2021: The White Paper was launched on May 4th 2021 in an online interactive webinar featuring policymakers, endocrinology experts and other interested parties who came together to discuss ‘why hormones matter in EU health policy’.
The event introduced the interlinkages between endocrinology and COVID-19 and had specific dedicated sessions for the four key chapters of the White Paper: obesity, cancer, rare diseases and endocrine disrupting chemicals.
In his opening remarks, John F. Ryan, Director for Public Health in DG SANTE said “I am impressed by the links made in the White paper to the Beating Cancer Plan, obesity, Farm to Fork, nutrition, as well as the European Reference Networks. All these issues are very relevant topics that are being looked at in the European Commission’s work plan.” Building on these remarks, President of ESE Prof. Dr. Andrea Giustina from San Raffaele Hospital in Milano said “COVID-19 has really highlighted the importance of endocrinology and hormones across all policy areas. Almost two thirds of people who were hospitalized for COVID-19 had a metabolic condition. Our White Paper is not the last step. It is a first step towards including endocrinology at the highest level of EU policy.”
The recording of this event will be available to watch on ESE's YouChannel HERE.
LAUNCH EVENT ON ‘WHY HORMONES MATTER IN EU HEALTH POLICY’ – ESE’ WHITE PAPER
April 2021: The European Society of Endocrinology (ESE) is organising a webinar to present its new White Paper on endocrinology, titled “Hormones in European Health Policies: How endocrinologists can contribute towards a healthier Europe”. The webinar will feature high level policy makers, experts and other interested parties to discuss ‘why hormones matter in EU health policy’.
The event will introduce the interlinkages between endocrinology and COVID-19 and will have specific dedicated sessions for four important health topics: obesity, cancer, rare diseases and endocrine disrupting chemicals. For each topic, a discussion will take place between involved policymakers and expert endocrinologists.
The event will take place on Tuesday 4 May 2021 from 10:00 to 12:00 noon CEST. Registration is now closed
This historical document, first of its kind in Europe, has now received endorsement of 45 National Endocrine Societies and seven ESE associated Specialist Societies representing the vast majority of the more than 20,000 Endocrinologists across Europe. We hope that you share our vision that it is a milestone in the life of ESE and a tremendous step toward the path of inclusion which we started two years ago and now brings our Society to be key in the creation of a true Global Endocrine community and as a trustworthy and proactive partner of European Institutions.
The event will be moderated by journalist Cathy Smith.
Times are in CEST.
10:00 Welcome by ESE president Prof. Dr. Andrea Giustina, President of the European Society of Endocrinology
(2019-2021), Member of the Italian Superior Health Council, Prorector and Chairman of the Institute of
Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS San Raffaele Hospital,
10:05 Introductory remarks by John F. Ryan, Director for Public Health at DG SANTE
10:10 The ESE White Paper: an overview of the role of hormones in health and disease in the pandemic and
MEP Sirpa Pietikäinen (EPP, Finland) and ESE President Prof. Dr. Andrea Giustina
10:20 Panel 1 Obesity: A societal challenge with a strong and complex connection to hormones
Prof. Dr. Liesbeth van Rossum – Head of Obesity Center, University of Rotterdam
MEP Cristian-Silviu Buşoi (EPP, Romania)
10:40 Panel 2 Rare diseases: Solutions for the more than 440 distinct rare diseases that affect the endocrine
The European Organisation for Rare Diseases (EURORDIS)
Prof. Dr. Alberto Pereira – Head of the Division of Endocrinology Leiden University Medical Centre
Coordinator of Endo-ERN
Johan de Graaf – patient representative Endo-ERN ePAG
Jose Valverde – Policy officer Digital Health and European Reference Networks at DG SANTE
11:00 Panel 3 Cancer: Prevention, treatment, care and quality of life all depend on hormones
Prof. Dr. Monica Marazuela, Chief of Endocrinology and Nutrition at La Princesa Hospital in Madrid
MEP Jytte Guteland (S&D, Sweden)
11:20 Panel 4 Endocrine disrupting chemicals: Exposure and health risks
Prof. Dr. Josef Köhrle, Institute of Experimental Endocrinology, Charité Berlin
Cristina de Avila – Head of Unit Sustainable Chemicals at DG Environment
11:40 Moderated discussion
11:55 Closing remarks by ESE president Prof. Dr. Andrea Giustina
ESE is grateful to the contributions of the affiliated national endocrine societies to our policy efforts, and to the ESE Corporate Members Ipsen, Pfizer, Recordati Rare Diseases and Takeda for providing unrestricted grant support to this webinar event.